NURS 6521-Walden University - Pharmacotherapy for Cardiovascular Disorders Case Study - Week 3
Week 3: Pharmacotherapy for Cardiovascular Disorders | Case Study 1 Main Discussion Post Case Study 1: Patient AO has a history of obesity and has recently gained 9 pounds. The patient has been diagnosed with hypertension and hyperlipidemia. Drugs currently prescribed include the following: • Atenolol 12.5 mg daily • Doxazosin 8 mg daily • Hydralazine 10 mg qid • Sertraline 25 mg daily • Simvastatin 80 mg daily Factor: Behavior While there can sometimes be a genetic link to hypertension and hyperlipidemia, lifestyle behaviors are more often a contributing factor. Obesity increases the risk of many diseases including, heart disease, diabetes, gastrointestinal problems, cancer, and breathing problems such as sleep apnea and asthma (Bombaci, 2017).NURS 6521-Walden University - Pharmacotherapy for Cardiovascular Disorders Case Study - Week 3
Written for
Document information
- Uploaded on
- September 11, 2021
- Number of pages
- 6
- Written in
- 2021/2022
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
-
week 3 pharmacotherapy for cardiovascular disorders | case study 1 main discussion post case study 1 patient ao has a history of obesity and has recently gained 9 pounds the patient has been diagno
